CorrlensCorrlens
Correlate

Correlation Analysis

BERKSHIRE HATHAWAY Class B vs United Therapeutics Corp

BRK.B vs UTHR

+0.804

Strong positive

When one moves up, the other tends to follow.

BRK.B logo

BERKSHIRE HATHAWAY Class B

BRK.B

Berkshire Hathaway is a holding company with a wide array of subsidiaries engaged in diverse activities. The firm's core business segment is insurance, run primarily through Geico, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group. Berkshire has used the excess cash thrown off from its operations to acquire Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy (utilities and energy distributors), and the companies that make up its manufacturing, service, and retailing operations (which include Precision Castparts, Lubrizol, Clayton Homes, Marmon, and IMC/ISCAR). The conglomerate is unique in that it is run on a completely decentralized basis. Berkshire is expected to generate close to $375 billion in revenue in 2025.

Market cap 1T

UTHR logo

United Therapeutics Corp

UTHR

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Market cap 24.5B · 1,400 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStock

Time Series

Relative Performance

Green: BRK.BGray: UTHR36 of 1,254 points (sampled)

Who Moves First

UTHR leads BRK.B by 6 days

UTHR tends to move before BRK.B.

After testing 13 timing shifts, the strongest relationship was +0.805 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.126

12 periods · Return correlation when both series rose

Both Falling

N/A

4 periods · Return correlation when both series fell

Diverging

-0.642

19 periods · Return correlation when series moved apart

R-Squared

64.7%

Share of variance in one series explained by the other.

Trend Agreement

58.4%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.784, 0.823]

Scatter

XY Regression

247250300350400450500522.1147200300400500597BERKSHIRE HATHAWAY Class BUnited Therapeutics CorpData pointsFit (r = 0.804)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

BRK.B logo

BERKSHIRE HATHAWAY Class B

BRK.B

Market cap 1T

Stock · 1,254 raw → 1,254 prepared

Series B

UTHR logo

United Therapeutics Corp

UTHR

Market cap 24.5B · 1,400 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

44

Estimated crossover points between normalized spreads.

Slope

0.8713

Linear regression slope.

Intercept

-53.4448

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 6 hours ago · ID: stock-brk-b-vs-stock-uthr-daily